Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Kepu Liu"'
Autor:
Jie Zhang, Kepu Liu, Zheng Zhu, Shihao Shang, Di Wei, Yu Zheng, Lei Zhang, Ying Liang, Dongen Ju, Jianlin Yuan
Publikováno v:
Frontiers in Oncology, Vol 14 (2024)
Urinary tumors pose a significant health threat because of their high prevalence and recurrence rates. Despite the availability of various treatment options, many patients poorly respond to traditional therapies, highlighting the urgent need for alte
Externí odkaz:
https://doaj.org/article/18c0436d5da748c2ae068bf232c1b356
Autor:
Shihao Shang, Lei Zhang, Kepu Liu, Maoxin Lv, Jie Zhang, Dongen Ju, Di Wei, Zelong Sun, Pinxiao Wang, Jianlin Yuan, Zheng Zhu
Publikováno v:
Exploration of Targeted Anti-tumor Therapy, Vol 5, Iss 3, Pp 641-677 (2024)
Bladder cancer (BC) is the tenth most common malignancy globally. Urothelial carcinoma (UC) is a major type of BC, and advanced UC (aUC) is associated with poor clinical outcomes and limited survival rates. Current options for aUC treatment mainly in
Externí odkaz:
https://doaj.org/article/c3d244504b6a48418937e0fada09e42a
Autor:
Maoxin Lv, Shihao Shang, Kepu Liu, Yuliang Wang, Peng Xu, Hao Song, Jie Zhang, Zelong Sun, Yuhao Yan, Zheng Zhu, Hao Wu, Hao Li
Publikováno v:
Pharmaceutics, Vol 16, Iss 8, p 1067 (2024)
Bacillus Calmette–Guérin (BCG) immunotherapy has been a cornerstone treatment for non-muscle-invasive bladder cancer for decades and still faces challenges, such as severe immune adverse reactions, which reduce its use as a first-line treatment. T
Externí odkaz:
https://doaj.org/article/77a9ff66b0f2454bb3924bd97f520ca2
Publikováno v:
Frontiers in Genetics, Vol 13 (2022)
Background: Renal cell carcinoma (RCC) is the predominant type of malignant tumor in kidney cancer. Finding effective biomarkers, particularly those based on the tumor immune microenvironments (TIME), is critical for the prognosis and diagnosis of RC
Externí odkaz:
https://doaj.org/article/d43519519d7c470b8bba6f5b8b4e71ea
Autor:
Kaiyun Pang, Guodong Li, Mouhan Li, Lan Zhang, Qinwei Fu, Kepu Liu, Wei Zheng, Zhiqiao Wang, Juan Zhong, Lijin Lu, Peijia Li, Yucan Zhou, Wanling Zhang, Qinxiu Zhang
Publikováno v:
Evidence-Based Complementary and Alternative Medicine. 2022:1-14
The prevalence of allergic rhinitis (AR) has increased tremendously in the recent year in China. Evidence-based medicine to objectively evaluate the prevalence and risk factors for AR in China is urgently required. Toward this, we systematically sear
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::02e3129fa44499aa50a367152d53ba06
https://doi.org/10.1155/2022/7165627
https://doi.org/10.1155/2022/7165627
Autor:
Shichao Han, Haotian Zheng, Fu Han, Xiaowei Zhang, Geng Zhang, Shuaijun Ma, Kepu Liu, Weijun Qin, Gaofeng Wu
Publikováno v:
Food Science & Nutrition. 10:3931-3941
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::649fd0b6226c9b04dce61a0938ee8f7f
https://doi.org/10.1002/fsn3.2989
https://doi.org/10.1002/fsn3.2989
Publikováno v:
Journal of Clinical Oncology. 40:e16510-e16510
e16510 Background: Increasing evidence has revealed that long non-coding RNAs (lncRNAs) play a crucial role in cancer immunity. However, the comprehensive landscape of immune infiltration-associated lncRNAs and their potential roles in the prognosis
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3b195cc7de7d7e095f3e07b79c4b907a
https://doi.org/10.1200/jco.2022.40.16_suppl.e16510
https://doi.org/10.1200/jco.2022.40.16_suppl.e16510
Publikováno v:
Transplantation proceedings. 45(9)
Organ transplantation is the best treatment of some end-stage diseases such as renal failure. Unfortunately, not every transplant is successful due to rejection or dysfunction of the transplanted organ. Induction of allograft tolerance is the most im
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::67d5207e1bf29ed91f563ac016edcb35
https://pubmed.ncbi.nlm.nih.gov/24182825
https://pubmed.ncbi.nlm.nih.gov/24182825